New Delhi, July 15: The central government has launched the third phase of the Biomedical Research Career Program to accelerate health research and healthcare innovation in the country. A budget of ₹1,500 crores has been allocated for this initiative, aimed at promoting fellowships, research grants, and transforming scientific discoveries into practical health services.
The Ministry of Science and Technology stated that ₹1,000 crores will be provided by the Department of Biotechnology (DBT), while ₹500 crores will come from the London-based Wellcome Trust. This partnership is seen as a significant step towards strengthening biomedical research in India on a global scale.
Dr. Jitendra Singh, the Union Minister of State for Science and Technology and Earth Sciences, emphasized that the program aims to create a world-class biomedical research ecosystem in India. It will train experts such as basic scientists, clinical researchers, public health experts, science communicators, and research managers. The initiative will also promote interdisciplinary and collaborative research.
He noted that this initiative will attract new international and philanthropic partnerships in the field of biomedical science in India, thereby increasing both the scope and impact of investment in research.
Dr. Singh stated that biotechnology is set to become a cornerstone of India’s economic growth, scientific advancement, and global competitiveness in the coming years. He revealed that India’s bio-economy has grown from $10 billion in 2014 to over $195 billion in 2025, with projections of reaching $300 billion by 2030.
Currently, there are approximately 12,000 active biotech startups in the country. India is among the world’s leading vaccine manufacturers and is rapidly establishing itself as a global biotech hub.
During the program, the formal launch of Phase III included discussions with scientists and researchers whose careers have been positively impacted by this initiative. Presentations were also made on the scientific achievements of the program and its long-term effects.
Dr. Singh remarked that this program exemplifies how long-term partnerships can accelerate scientific research, develop world-class human resources, and address national and global health challenges.
He urged industries and philanthropic organizations to invest more in this sector, stating that while India has no shortage of talent and innovation, sustained financial support is crucial for transforming research into technology, diagnostics, and affordable healthcare services.
Leave a Comment